Central America vs Uruguay: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
Uruguay
96.0%
in 2024
Central America rank
13th
Uruguay rank
16th
Proportion of the target population who received a 3rd dose of over time
- Central America
- Uruguay
How they compare
Uruguay currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes Uruguay's figure about 1.2 times Central America's.
Across all 15 years both countries report, Uruguay has been ahead every year.
Central America ranks 13th and Uruguay ranks 16th of 37 groups.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central America | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.5% | 93.4% | 6.9% | Uruguay |
| 2020s | 81.4% | 94.4% | 13.0% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or Uruguay?
- Uruguay, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and Uruguay?
- 16.0%, with Uruguay ahead.
- How many years of comparable data are there for Central America and Uruguay?
- 15 years are reported by both, from 2010 to 2024.
- How do Central America and Uruguay rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and Uruguay ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.